What type of study is this?

September 28, 2025Diabetes Technology & Therapeutics

A Real-World Study Comparing Advanced Hybrid Closed-Loop Systems During Pregnancy in Women with Type 1 Diabetes

View Full Paper

Ask AI

Bookmark

Advanced hybrid closed-loop systems significantly improve maternal glucose metrics during pregnancy in women with type 1 diabetes.
The MiniMed 780G®, CamAPS® FX, and Tandem Control-IQ systems were evaluated for efficacy in a real-world cohort.
Assessment involved analyzing pregnancy outcomes and glucose metrics in a multicenter setting focused on maternal health.
Results suggest potential for better management of type 1 diabetes during pregnancy with advanced technologies.

Implication

Real-world study compares maternal glucose outcomes among three advanced hybrid systems, highlighting implications for pregnancy management.

Abstract

Objective: To compare maternal glucose metrics and pregnancy outcomes of three advanced hybrid closed-loop (aHCL) systems (MiniMed 780G®, CamAPS® FX, and Tandem Control-IQ) in a real-world, multicenter cohort of pregnant women with type 1 diabetes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Quirós et al. (2025) studied this question.

synapsesocial.com/papers/68d90bc941e1c178a14f72bc https://doi.org/10.1177/15209156251379488

View Full Paper

Ask AI

Bookmark

Implication

Real-world study compares maternal glucose outcomes among three advanced hybrid systems, highlighting implications for pregnancy management.

A Real-World Study Comparing Advanced Hybrid Closed-Loop Systems During Pregnancy in Women with Type 1 Diabetes

Key Points

Implication

Abstract

Discussion

Cite This Study

A Real-World Study Comparing Advanced Hybrid Closed-Loop Systems During Pregnancy in Women with Type 1 Diabetes

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading